Financials in USD. Standardized financial statements.
A compact view of how Pfizer Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $62.58B | $63.63B | $59.55B | $100.33B | $81.29B | $41.65B | $41.17B | $53.65B | $52.55B | $52.82B |
| Revenue Growth? | -1.6% | +6.8% | -40.6% | +23.4% | +95.2% | +1.2% | -23.3% | +2.1% | -0.5% | 0.0% |
| Cost of Revenue? | $18.57B | $21.78B | $29.21B | $38.24B | $34.41B | $11.77B | $12.62B | $16.01B | $15.78B | $15.95B |
| Gross Profit? | $44.01B | $41.85B | $30.34B | $62.09B | $46.88B | $29.88B | $28.55B | $37.64B | $36.77B | $36.87B |
| Gross Margin? | +70.3% | +65.8% | +50.9% | +61.9% | +57.7% | +71.7% | +69.3% | +70.2% | +70.0% | +69.8% |
| Operating Expenses? | $28.58B | $25.36B | $25.05B | $24.54B | $26.08B | $20.80B | $21.04B | $22.35B | $22.38B | $22.60B |
| Operating Income? | $15.44B | $16.48B | $5.29B | $37.55B | $20.79B | $9.09B | $7.51B | $15.29B | $14.39B | $14.27B |
| EBITDA? | $15.10B | $18.13B | $9.56B | $41.03B | $30.79B | $13.17B | $18.85B | $19.59B | $19.84B | $15.29B |
| Income Before Tax | $7.52B | $8.02B | $1.06B | $34.73B | $24.31B | $7.04B | $11.48B | $11.88B | $12.30B | $8.35B |
| Income Tax Expense | -$266.00M | -$28.00M | -$1.11B | $3.33B | $1.85B | $370.00M | $618.00M | $706.00M | -$9.05B | $1.12B |
| Net Income? | $7.77B | $8.02B | $2.13B | $31.36B | $22.15B | $9.16B | $16.27B | $11.15B | $21.30B | $7.21B |
| EPS? | $1.36 | $1.42 | $0.38 | $5.59 | $3.95 | $1.65 | $2.92 | $1.90 | $3.57 | $1.18 |
| Diluted EPS? | $1.36 | $1.41 | $0.37 | $5.47 | $3.88 | $1.63 | $2.87 | $1.87 | $3.52 | $1.17 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality